大熊猫肌肉肌酸激酶的纯化与性质

用改进的Ｋｕｂｙ等人方法从大熊猫骨骼肌中纯化了肌酸激酶，并对此酶的某些性质进行了研究。纯化倍数为 ３５．７；收率１７．３％；比活力为 ５５．３Ｕ／ｍｇ；等电点为 ６．６０。聚丙烯酰胺凝胶电泳鉴定为一条带。ＳＤＳ聚丙烯酰胺凝胶电泳测得其亚基分子量为４２ ０００，总分子量为 ８４ ０００，该酶是由两个相同亚基组成的二聚体。酶对肌酸的Ｋｍ 为 ５．２６ｍｍｏｌ／Ｌ；对ＡＴＰ的 Ｋｍ为 ０．７４ｍｍｏｌ／Ｌ，酶的最适温度是 ３０～３６℃；酶的最适ｐＨ大于８．０。     

The possible involvement of protein kinase C and phospholipase A2 inHydra tentacle regeneration

The participation of protein kinase C (PKC) in the regeneration of tentacles ofHydra vulgaris was studied. Regeneration was induced by 1,2-sn-dioctanoyl-glycerol (diC₈) and the novel diterpenoidic diacylglycerol verrucosin B (VB), a potent PKC activator extracted from marine sources. VB substantially increasedHydra average tentacle number (ATN) at concentrations 10,000 times lower than those needed for diC₈ to exert an analogous effect. When both synthetic and natural VB analogues were tested, the structure/activity relationship found inHydra tentacle regeneration was identical to that known for DAG-induced activation of PKC in vitro. VB-induced increase of ATN was strongly counteracted by the PKC inhibitors sphingosine and A3, but was not synergic with a tenfold increase of extracellular Ca²⁺ concentration or with an increase of intracellular Ca²⁺ concentration obtained either with the ionophore A23187 or with thapsigargin. This suggested the involvement of a non-Ca²⁺-dependent PKC in VB-triggeredHydra tentacle regeneration. The involvement of phospholipase A₂ (PLA₂) activation inHydra regenerative processes was studied using the novel site-specific inhibitor of the enzyme, oleyloxyethylphosphorylcholine (OOPC), which brought about a striking inhibition of ATN in the low molar range. This effect was reversed by arachidonic acid (AA), while an enhancement of ATN was also observed with an inhibitor of AA uptake from membrane phospholipids, thus suggesting that PLA₂-catalysed liberation of AA is involved inHydra tentacle regeneration. OOPC also blocked verrucosin B-induced PKC-mediated enhancement of ATN, thus suggesting that this effect is also mediated by PLA₂ activation. ATN was increased also by compound 48/80, a direct activator of pertussis toxin-sensitive GTP-binding proteins, and this effect was counteracted by pertussis toxin pretreatment. None of the known AA cascade inhibitors exhibited an effect on ATN comparable to that exerted by OOPC, but, surprisingly, the cycloxygenase inhibitor indomethacin strongly enhanced ATN, thus suggesting that prostanoids might effect a negative control onHydra regenerative processes. This represents the first attempt so far reported to study the implication of more than one biochemical pathway as a signalling event in the hydroid regenerative processes.     

NO对新生大鼠心肌细胞PKC活性的影响

利用培养新生大鼠心肌细胞，检测NO前体L-精氨酸(L-arginine,L-Arg)和NO供体硝普钠(sodium nitroprusside,SNP)对PKC活性的影响，并探讨内、外源性NO在PKC激动剂佛波指(phorbol 12-myristate 13-acetate,PMA)激活PKC中的作用.实验结果表明：培养基中加入L-Arg，PKC活性呈剂量依赖性降低；用L-Arg进行预处理，30 min后加入PMA，PKC活性明显降低，与单纯PMA组相比有显著差异；NOS抑制剂L-NAME本身对基础状态PKC活性无明显影响，但可阻断L-Arg对上述2个效应的影响；培养液中加入NO供体SNP，PKC活性呈剂量依赖性降低；用SNP预处理心肌细胞，5 min后加入PMA，PKC活性与单纯PMA组相比有显著性差异.以上结果表明，内、外源性NO均具有剂量依赖性抑制PKC活性的作用，PKC可能是NO对心肌细胞作用的胞内信号传导通路的关键部位或重要信号分子之一；L-Arg通过NOS先生成NO，NO再对PKC起抑制作用.     

Platelet-derived growth factor receptor-β in myocyte was upregulated by angiotensin Ⅱ

To observe the regulation of platelet-derived growth factor (PDGF) receptor-βin myocyte stimulated by angiotensin II (AngII) at both integrated and cellular levels and reveal the signal transduction mechanism in cell, two kidneys, one clip (2K1C) renal hypertension were performed by placing a sliver clip around the left renal artery. Blood pressure and the ratio of left ventricular weight to body weight were measured at 4 and 8 weeks after operation. The content of AngII in heart was detected by radioimmunology assay; the protein level of PDGF receptor-βin heart was measured by Western blot analysis. The alteration of PDGF receptor-βstimulated by AngII and several inhibitors was observed on cultured neonatal rat ventricular myocyte (NRVM). The content of AngII in heart of 2K1C renal hypertensive rat at 4 and 8 weeks after operation was increased. Compared with sham group, 4 and 8 weeks after operation, PDGF receptor-βin heart of 2K1C group was upregulated by 100.3% and 127.1% (P < 0.05), respectively. This upregulation could be inhibited by captopril. For cultured myocyte, PDGF receptor-βwas increased by 47.1% after being stimulated by AngII and this upregulation could be inhibited by losartan which was an inhibitor of AT1 receptor. PLC inhibitor (U73122) and MEK inhibitor (PD98059) could partly inhibit PDGF receptor-βupregulation induced by AngII. These results suggested that AngII could upregulate PDGF receptor-βin myocyte by its AT1 receptor and this effect was at least partly dependent on PLC and extracellular signal-regulated kinase (ERK).     

一氧化氮的细胞内信号转导

从多个方面对一氧化氮(NO)的细胞内信号转导途径进行了阐述。     

Wip1 protects hydrogen peroxide-induced colonic epithelial barrier dysfunction

Tight junctions (TJs) create a paracellular permeability barrier. Although reactive oxygen species have been implicated as mediators of inflammation in inflammatory bowel diseases, their influence on the function of colonic epithelial TJs remains unknown. Oxidative stress-mediated colonic epithelial permeability was significantly attenuated by a p38 mitogen-activated protein (MAP) kinase inhibitor, SB203580. Although the amount of TJ proteins was not altered, hydrogen peroxide (H₂O₂) changed the localization of claudin-4 protein from an NP-40 insoluble fraction to a soluble fraction and from an apical TJ to lateral membrane. The p38 MAP kinase inactivator Wip1 significantly attenuated phosphorylation of p38 MAP kinase, and oxidative stress mediated permeability. H₂O₂-induced changes in claudin-4 localization were abolished by SB203580 pretreatment as well as Wip1-expressing adenovirus infection. This is the first study to demonstrate that exogenous Wip1 functions to protect oxidative stress-mediated colonic mucosal permeability and that H₂O₂-induced claudin-4 dislocalization is abolished by Wip1. Received 14 June 2007; received after revision 8 October 2007; accepted 8 October 2007     

Oncogenic mechanisms in myeloproliferative disorders

Myeloproliferative disorders (MPDs) are clonal haematopoietic malignancies involving the abnormal proliferation of myeloid lineages. The World Health Organisation (WHO) classification of haematopoietic malignancies distinguishes MPDs from myelodysplastic/ myeloproliferative disorders and systemic mastocytosis. These malignancies frequently involve constitutive tyrosine kinase activity, resulting from either oncogenic fusion protein production or from point mutations. Chronic myelogenous leukaemia is the model used for studies of the consequences of such molecular defects. However, the heterogeneity of the clinical course of MPDs should be seen in a more rationale conceptual framework, including the many molecular events associated with these diseases. This review focuses on the various tyrosine kinase-related molecular mechanisms underlying both MPDs and rare diseases with myeloproliferative features. We pay particular attention to the newly identified JAK2 V617F mutation in polycythaemia vera, essential thrombocythaemia and idiopathic myelofibrosis and deal with disease heterogeneity and putative additional molecular mechanisms. Received 9 June 2006; received after revision 28 July 2006; accepted 11 September 2006     

The epidermal growth factor receptor family: Biology driving targeted therapeutics

The epidermal growth factor family of receptor tyrosine kinases (ErbBs) plays essential roles in regulating cell proliferation, survival, differentiation and migration. The ErbB receptors carry out both redundant and restricted functions in mammalian development and in the maintenance of tissues in the adult mammal. Loss of regulation of the ErbB receptors underlies many human diseases, most notably cancer. Our understanding of the function and complex regulation of these receptors has fueled the development of targeted therapeutic agents for human malignancies in the last 15 years. Here we review the biology of ErbB receptors, including their structure, signaling, regulation, and roles in development and disease, then briefly touch on their increasing roles as targets for cancer therapy.     

过表达甘油激酶三角褐指藻藻株富集油脂的研究

为了得到高产并符合生物柴油标准的微藻油脂的藻株,本文研究了在外源甘油存在的情况下野生型（WT）三角褐指藻（Phaeodactylum tricornutum）,甘油激酶过表达藻株（GKOE）以及甘油激酶RNA干扰藻株（GKRNi）在添加浓度为20 mmol/L外源甘油的培养基中的生长情况、油脂产量以及脂肪酸组成.结果显示：（1）甘油兼养的GKOE藻细胞浓度可达到2.23×107个/mL,明显高于甘油兼养的WT的1.79×107个/mL和GKRNi的1.78×107 个/mL;（2）甘油兼养的GKOE油脂含量可达到31.73%,比甘油兼养的WT和GKRNi分别高了27.20%和26.63%;（3）尼罗红染色显示甘油兼养的GKOE荧光强度比甘油兼养的WT和GKRNi分别高16.26%和17.83%;（4）甘油兼养的GKOE总脂肪酸产量可达到0.052 mg/mL,比甘油兼养的WT和GKRNi高了36.84%和10.64%,说明其油脂适合于生物柴油开发.     

混合拥挤试剂对人肌肌酸激酶稳定性的影响作用研究

为了更加真实地模拟细胞内环境,在人肌肌酸激酶(HCK)的去折叠环境中同时加入了大分子拥挤试剂(葡聚糖)和小分子渗透剂(蔗糖),采用酶活性、荧光发射谱和溶液浊度检测等方法研究肌酸激酶在含有蔗糖和葡聚糖的混合拥挤环境中的稳定性,结果表明在肌酸激酶盐酸胍变性过程中,蔗糖不仅抑制肌酸激酶酶活性的丧失,还稳定肌酸激酶的构象,而葡聚糖对肌酸激酶保护能力相对较弱.对于热变性过程,相同质量浓度的蔗糖和葡聚糖能同等程度地减缓肌酸激酶活性的丧失,并抑制聚沉的产生.在葡聚糖和蔗糖同时存在的情况下,两者的保护作用可以累加,并共同维持肌酸激酶的稳定性.